A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Clinical trial NCT06504524 · COMPLETED
Trial details
- NCT number
- NCT06504524
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-05-31
- Enrollment
- 633
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.